Michael H. Carrel: 2025 was an exceptional year at AtriCure, Inc. with achievements across our business. This trial is evaluating the benefit of our AtriClip devices on non-AFib patients undergoing ...
With that, I will turn the call over to Glaukos Corporation’s Chairman and CEO, Thomas William Burns. Today, Glaukos Corporation reported record fourth quarter consolidated net sales of $143.1 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results